# Lantus in the Treatment of Type 1 Diabetes Children

> **NCT00206401** · PHASE4 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 60 (—)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Lantus and short acting analogs Vs NPH and short acting analogs

## Key facts

- **NCT ID:** NCT00206401
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 60 (—)
- **Last updated:** 2016-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00206401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00206401, "Lantus in the Treatment of Type 1 Diabetes Children". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00206401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*